Clinical trial
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in…
NCT00268723 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00268723 |
|---|---|
| Title | Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB |
| Official title | An Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Versus Placebo in Prevention of EIB in Subjects 18 Years of Age and Older With EIB |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Exercise-induced Bronchospasm |
| Intervention type | Drug |
| Interventions | Levalbuterol tartrate HFA MDI, Placebo |
| Enrollment | 15 |
| Start date | Dec 1, 2005 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Dec 22, 2005 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: